- Home
- HE vs PRAX Comparison
HE vs PRAX Comparison
Compare HE & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HE
- PRAX
- Stock Information
- Founded
- HE 1891
- PRAX 2015
- Country
- HE United States
- PRAX United States
- Employees
- HE N/A
- PRAX N/A
- Industry
- HE Electric Utilities: Central
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- HE Utilities
- PRAX Health Care
- Exchange
- HE Nasdaq
- PRAX Nasdaq
- Market Cap
- HE 1.8B
- PRAX 1.5B
- IPO Year
- HE N/A
- PRAX 2020
- Fundamental
- Price
- HE $9.17
- PRAX $70.54
- Analyst Decision
- HE Hold
- PRAX Strong Buy
- Analyst Count
- HE 3
- PRAX 9
- Target Price
- HE $10.67
- PRAX $146.33
- AVG Volume (30 Days)
- HE 3.5M
- PRAX 309.5K
- Earning Date
- HE 02-11-2025
- PRAX 03-04-2025
- Dividend Yield
- HE N/A
- PRAX N/A
- EPS Growth
- HE N/A
- PRAX N/A
- EPS
- HE N/A
- PRAX N/A
- Revenue
- HE $3,689,272,000.00
- PRAX $1,605,000.00
- Revenue This Year
- HE $3.17
- PRAX N/A
- Revenue Next Year
- HE N/A
- PRAX N/A
- P/E Ratio
- HE N/A
- PRAX N/A
- Revenue Growth
- HE N/A
- PRAX N/A
- 52 Week Low
- HE $7.61
- PRAX $33.01
- 52 Week High
- HE $18.19
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- HE 44.97
- PRAX 46.51
- Support Level
- HE $9.69
- PRAX $60.07
- Resistance Level
- HE $10.01
- PRAX $71.21
- Average True Range (ATR)
- HE 0.37
- PRAX 4.07
- MACD
- HE -0.00
- PRAX -0.79
- Stochastic Oscillator
- HE 54.23
- PRAX 49.11
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.